You are here

OpenMarket: Health Care

  • #NeverNeed Regulations and the Coronavirus

    June 11, 2020
    What is the appropriate public policy response to COVID-19 crisis? In a new short video, Kent Lassman makes the case for lifting government barriers that block people’s ingenuity and ability to fight the coronavirus. For lifting restrictions on access to health care providers and treatments. And for removing regulations that block access to capital for businesses or that stop them from hiring people.
  • A New Approach to COVID-19 Response

    May 14, 2020
    The new coronavirus—SARS-CoV-2, which causes the disease COVID-19—is here to stay until either a vaccine or herd immunity limits the number of people susceptible to transmission. A vaccine is a year or more away. So why do we continue to pursue lockdowns that ensure herd immunity will never develop and the virus will continue to fester?
  • Medical Supply Sterilization Plant Employee Corrects Chicago Tribune’s Misleading Coverage

    April 14, 2020
    An April 13 letter to the editor in the Chicago Tribune addresses the paper’s misleading and alarmist narrative about the use of ethylene oxide (EtO). The letter’s author is a far more credible expert on the topic than the Tribune journalists; therefore, it deserves some attention.
  • How SEC Accounting Regulations Hindered National Stockpile—and Still May Be Doing So

    April 9, 2020
    In a new report, CEI experts outline #NeverNeeded regulations that are frustrating responses to the pandemic and its aftermath. Among those is an obscure Securities and Exchange Commission regulatory “guidance” document that may be hindering production and distribution of much-needed medical supplies.
  • Antitrust Policy #NeverNeeded and Dangerous in a Crisis

    April 1, 2020
    The Justice Department and Federal Trade Commission will now allow some collaboration between companies to address the corona virus health threat. They also warned a frazzled business community that certain practices could still land them in antitrust hot water. The uncertainty will prevent some ideas from being tried and deny citizens the benefits of what could have been.
  • Getting Rid of #NeverNeeded Regulations Hindering Coronavirus Response

    March 18, 2020
    What can Washington do to minimize harm from the coronavirus? Some of the best policy responses are coming not from imposing new regulations, but from loosening old ones. In fact, many such rules were never needed in the first place. To that end, a Twitter hashtag, #NeverNeeded, is collecting a small but growing list of ideas for rules to get rid of, as well as rules that already have been eased.
  • Liberty in the Time of Coronavirus Part 2

    March 16, 2020
    Much of the money dedicated to medical research and services comes from the federal government. While some may see this is a good way to coordinate efforts on important health goals, libertarians have criticized this top-down influence for corrupting the reliability of research.
  • Proposals for and Problems with International Drug Reference Pricing

    November 5, 2019
    Healthcare costs remain top of mind in American politics. Polls consistently show that healthcare is one of, if not the top, priority for voters heading into the 2020 election cycle. Politicians and other policymakers face a looming crisis with healthcare expenditures. Medicare and Medicaid, the federal single-payer programs for the elderly and indigent, comprised over a quarter of all federal spending in 2018. This share is rising.
  • Gene Editing Can Improve Health Outcomes for the Poor

    September 9, 2019
    Gene editing, specifically somatic gene therapy, cures maladies with traceable genetic origins. This revolutionary science is rapidly advancing, but not without major setbacks. Regulations designed to protect patients from dangerous applications of gene editing, both real and imaginary, are increasing the cost, slowing development, and preventing life-saving research.
  • Department of Health and Human Services Needs to Correct Record on Marijuana

    June 12, 2019
    Regulators at the federal Drug Enforcement Agency (DEA) had an opportunity in 2016 to move marijuana into a less restrictive category of controlled substances. This could have ended the ongoing conflict between federal law, which considers the sale of marijuana illegal in all cases, and the laws of the states, almost all of which consider some form of marijuana legal. The DEA, however, rejected petitions to reclassify marijuana.

Pages

Subscribe to OpenMarket: Health Care